港股药品股集体下跌，三生制药(01530.HK)跌超8%，中国生物制药(01177.HK)跌超2%，翰森制药(03692.HK)、石药集团(01093.HK)跌超1%。

Group 1 - The Hong Kong pharmaceutical stocks experienced a collective decline, with notable drops in specific companies [1] - Three-Sixty Pharmaceuticals (01530.HK) fell over 8%, indicating significant market pressure [1] - China Biopharmaceutical (01177.HK) decreased by more than 2%, reflecting a broader trend in the sector [1] Group 2 - Hansoh Pharmaceutical (03692.HK) and CSPC Pharmaceutical Group (01093.HK) both saw declines exceeding 1%, contributing to the overall downturn in the industry [1]